Table of Contents
Hepatitis Research and Treatment
Volume 2010, Article ID 275274, 2 pages
http://dx.doi.org/10.1155/2010/275274
Editorial

Pegylated Interferon and Ribavirin Treatment for Hepatitis C Virus Infection

1Department of Gastroenterology, Tokai University School of Medicine, 143 Shimokasuya, Isehara 259-1193, Japan
2Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University Medical Center, Palo Alto, CA 94304-1509, USA
3Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 801, Taiwan

Received 25 November 2010; Accepted 25 November 2010

Copyright © 2010 Tatehiro Kagawa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Tatehiro Kagawa, Emmet B. Keeffe, and Ming-Lung Yu, “Pegylated Interferon and Ribavirin Treatment for Hepatitis C Virus Infection,” Hepatitis Research and Treatment, vol. 2010, Article ID 275274, 2 pages, 2010. https://doi.org/10.1155/2010/275274.